SOUTH SAN FRANCISCO, Calif., Jan. 3, 2024 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company’s president and CEO, will present a company overview at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024 at 12:00 p.m. PT in San Francisco, CA. To access the live webcast… Continue reading Rigel to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Tag: Morgan
South Rampart Pharma to Present at Biotech Showcase 2024
Hernan Bazan, MD, FACS, CEO and Co-Founder, will provide a company update on SRP-001, the first-in-class non-opioid analgesic with FDA Fast Track designation during JP Morgan Healthcare week NEW ORLEANS, Jan. 3, 2024 /PRNewswire/ — South Rampart Pharma, Inc. (“South Rampart” or the “Company”), a clinical-stage life science company pioneering innovative pain treatments, announced today that… Continue reading South Rampart Pharma to Present at Biotech Showcase 2024
AllianceBernstein obtains China mutual fund business licence
U.S.-based AllianceBernstein Holding LP has obtained a license to run its wholly-owned mutual fund business in China, the company said on Tuesday, making it the latest foreign asset manager to tap China’s $3.8 trillion mutual fund market. “AllianceBernstein will offer Chinese investors onshore investment products and solutions, and help them explore opportunities in China’s domestic… Continue reading AllianceBernstein obtains China mutual fund business licence
Danaher to Present at J.P. Morgan Healthcare Conference
WASHINGTON, Jan. 2, 2024 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 9, 2024 at 2:15 p.m. ET. The event will be simultaneously webcast on www.danaher.com. ABOUT DANAHERDanaher is a leading… Continue reading Danaher to Present at J.P. Morgan Healthcare Conference
Syndax Announces Presentation at 42nd Annual J.P. Morgan Healthcare Conference
WALTHAM, Mass., Jan. 2, 2024 /PRNewswire/ — Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer of Syndax, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 5:15 p.m. PT/ 8:15 p.m. ET.… Continue reading Syndax Announces Presentation at 42nd Annual J.P. Morgan Healthcare Conference
Neurocrine Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
SAN DIEGO, Jan. 2, 2024 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the 42nd Annual J.P. Morgan Healthcare Conference at 9:45 a.m. Pacific Time on Tuesday January 9, 2024 in San Francisco. Kevin Gorman, Chief Executive Officer, will present at the conference. The live presentation will be webcast and may be accessed… Continue reading Neurocrine Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Avanos Medical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference
ALPHARETTA, Ga., Jan. 2, 2024 /PRNewswire/ — Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, California on Monday, Jan. 8 at approximately 3:45 p.m., PST. A webcast of the conference presentation will be available on the Investors section of the… Continue reading Avanos Medical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference
BillionToOne to Present at the 42nd Annual J.P. Morgan Healthcare Conference
MENLO PARK, Calif., Jan. 2, 2024 /PRNewswire/ — BillionToOne, a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that Oguzhan Atay, PhD, CEO, will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on January 10, 2024. Presentation details… Continue reading BillionToOne to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Totus Medicines to Present at 42nd Annual J.P. Morgan Healthcare Conference
EMERYVILLE, Calif., Jan. 2, 2024 /PRNewswire/ — Totus Medicines, a company revolutionizing small molecule drug discovery and development through the use of covalent libraries and AI tools, announced today today announced that Totus President and CEO, Nassim Usman, Ph.D., will be presenting a corporate update at the 42nd Annual J.P. Morgan Healthcare Conference in San… Continue reading Totus Medicines to Present at 42nd Annual J.P. Morgan Healthcare Conference
AbbVie to Present at the 42nd Annual J.P. Morgan Healthcare Conference
NORTH CHICAGO, Ill., Jan. 2, 2024 /PRNewswire/ — AbbVie (NYSE: ABBV) will participate in the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024. Robert A. Michael, president and chief operating officer, Scott T. Reents, executive vice president, chief financial officer, Jeffrey R. Stewart, executive vice president, chief commercial officer and Roopal Thakkar,… Continue reading AbbVie to Present at the 42nd Annual J.P. Morgan Healthcare Conference